Background Acetylcholinesterase inhibitors, such as neostigmine, have traditionally been
used for reversal of non‐depolarizing neuromuscular blocking agents. However, these …

Background and objective Sugammadex has been introduced for reversal of rocuronium (or
vecuronium)–induced neuromuscular blockade (NMB). Although its efficacy has been …

Sugammadex is the first clinical representative of a new class of drugs called selective
relaxant binding agents. It has revolutionized the way anesthesiologists think about drug …

Retrospective investigation of postoperative outcome after r... : European Journal of
Anaesthesiology | EJA Retrospective investigation of postoperative outcome after reversal of …

Objective The aim of the study is to evaluate the clinical and economic impact of introducing
a rocuronium–neostigmine–sugammadex strategy into a cisatracurium–neostigmine …

Objective To compare sugammadex and neostigmine regarding the efficacy in reversing
rocuronium-induced neuromuscular block, the incidence of post-operative respiratory …

Objectives/Hypothesis The use of neuromuscular blocking agent may effect intraoperative
neuromonitoring (IONM) during thyroid surgery. An enhanced neuromuscular‐blockade …

Background: The aim of this prospective audit was to investigate clinical practice related to
muscle relaxant reversal and the impact made by the recent introduction of sugammadex on …

Sugammadex is a reversal agent that was engineered to reverse the effects of aminosteroid
muscle relaxants. It is a modified gamma-cyclodextrin, ie a large glucose molecule bound in …

This article reviews the literature on development of neuromuscular blockade management
in thyroid surgery with intraoperative neural monitoring (IONM) in the past decade …